Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-06-Speech-3-355-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110406.29.3-355-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I supported this resolution as I think that health claims can influence the choices made by consumers, which is why these claims must be used responsibly, based on the highest quality scientific evaluations. It is certainly true that the presence of DHA in breast milk has a positive impact on the visual development of infants up to 12 months. However, this does not automatically mean that synthesised DHA, included in other forms of milk for infants, has the same effect. In breast milk, DHA is accompanied by other co-enzymes and co-factors, which jointly produce this effect on visual development. At the moment, there is no consensus among the scientific community on the positive effects that DHA fortified milk formulae have on infants. This is why I think that it is premature for us to authorise the use of such a claim until we have tangible scientific proof for this. This kind of health claim may mislead consumers and have undesirable effects on their children’s health."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples